Molsidomine

CAS No. 25717-80-0

Molsidomine( Corvaton | Morsydomine )

Catalog No. M13777 CAS No. 25717-80-0

Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
100MG Get Quote In Stock
200MG 28 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Molsidomine
  • Note
    Research use only, not for human use.
  • Brief Description
    Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine.
  • Description
    Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine, which is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Corvaton | Morsydomine
  • Pathway
    NF-κB
  • Target
    NOD
  • Recptor
    NOD
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    25717-80-0
  • Formula Weight
    242.23
  • Molecular Formula
    C9H14N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    O=C([N-]C1=C[N+](N2CCOCC2)=NO1)OCC
  • Chemical Name
    (ethoxycarbonyl)(3-morpholino-1,2,3-oxadiazol-3-ium-5-yl)amide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rosenkranz B, et al. Clin Pharmacokinet. 1996 May;30(5):372-84.
molnova catalog
related products
  • Z-Asp-CH2-DCB

    Z-Asp-CH2-DCB is an irreversible inhibitor of broad spectrum caspase.

  • JC-171

    JC-171 is a selective NLRP3 inflammasome inhibitor that inhibits LPS/ATP-induced IL-1β release from macrophages with IC50 of 8.45 uM.

  • NLRP3-IN-10

    NLRP3-IN-10 (ZVN26391) is a potent NLRP3 inhibitor. NLRP3-IN-10 inhibits IL-1β release with an IC50 value of 251.1 nM.